[Federal Register Volume 89, Number 144 (Friday, July 26, 2024)]
[Notices]
[Pages 60636-60638]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-16492]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-24-24HQ; Docket No. CDC-2024-00057]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed information 
collection, as required by the Paperwork Reduction Act of 1995. This 
notice invites comment on a proposed information collection project 
titled ``Division of Diabetes Translation Programmatic & Participant 
User Experience Data Collection'' (DDTDC). This Generic information 
collection, will enable CDC's Division of Diabetes Translation (DDT) to 
collect data required in a timely manner to support the development, 
refinement, and improvement of DDT's education, training, technical 
assistance (TA), and communication/marketing activities.

DATES: CDC must receive written comments on or before September 24, 
2024.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0057 by either of the following methods:
     Federal eRulemaking Portal: www.regulations.gov. Follow 
the instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to www.regulations.gov.
    Please note: All public comment should be submitted through the 
Federal eRulemaking portal (www.regulations.gov) or by U.S. mail to the 
address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7118; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of the existing collection 
of information, and each reinstatement of previously approved 
information collection before submitting the collection to the OMB for 
approval. To comply with this requirement, we are publishing this 
notice of a proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information,

[[Page 60637]]

including the validity of the methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of collecting information on those to 
respond, including using appropriate automated, electronic, mechanical, 
or other technological collection techniques or other forms of 
information technology, e.g., permitting electronic responses; and
    5. Assess information collection costs.

Proposed Project

    Division of Diabetes Translation Programmatic & Participant User 
Experience Data Collection (DDTDC)--New--National Center for Chronic 
Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    The Division of Diabetes Translation (DDT) plays a crucial role in 
helping prevent Type 2 diabetes, reducing diabetes complications and 
disability, and reducing diabetes-related disparities across the United 
States. DDT accomplishes this by providing education, training, 
technical assistance (TA), and engaging in communication/marketing 
activities for various key audiences. These customers include national, 
state, and local partners, grantees, providers (e.g., lifestyle 
coaches, diabetes educators, healthcare providers, health/medical and 
community-based organizations), people with prediabetes, diabetes and 
their family, friends, and caregivers, and other consumers of DDT 
products and programs.
    For DDT to be able to efficiently and effectively do this work and 
fulfill its mission, it needs to be able to collect information and 
feedback from intended audiences in a timely manner and with enough 
frequency to ensure DDT can deliver clear, effective, efficient, and 
appropriate customer service. This includes, for instance, collecting 
data on key audiences' needs, and on the reach, uptake, use, customer 
experience and satisfaction with DDT's services, products, and related 
programs, including its education, training, TA and communications 
services and products. However, in the interest of timely provision of 
services, DDT often forgoes the important step of getting input from 
its key audiences on the clarity, efficiency, effectiveness, and 
appropriateness of the services and resources it develops and provides 
for them. Skipping this information collection step, or doing so with 
less frequency, avoids the delay involved in the standard OMB review 
process increases the risk of DDT wasting both time and money 
developing and providing education, training, TA, and communication/
marketing that will not achieve the intended objectives and will be 
unclear, irrelevant, or not fully meet the needs of DDT's audiences. It 
can also have other unintended consequences, such as jeopardizing the 
credibility of Federal health officials.
    The Division of Diabetes Translation Programmatic & Participant 
User Experience Data Collection (DDTDC) will enable DDT to collect the 
information they require in a timely manner to:
     Provide clear, effective, efficient, appropriate, and 
timely education, communication, training, and technical assistance to 
key audiences and other interested groups, including consumer audiences 
(e.g., people with prediabetes, diabetes, and their family, friends, 
and caregivers), providers (e.g., lifestyle coaches, diabetes care and 
education specialists, healthcare and other providers, health/medical 
and community-based organizations); and partners (national, state, and 
local partners).
     Ensure quality and prevent duplication in the development 
and dissemination of prevention and health information and program 
activities by DDT to consumers, providers, and state and local 
partners.
     Conduct exploratory/formative assessments to inform DDT's 
development of education, communication/marketing, training, and 
programmatic materials, tools, and resources to support and improve the 
prevention and management of diabetes. For example, identifying key 
audiences' knowledge, attitudes, behaviors, motivators, and information 
needs.
     Assess the impact of programs, messages, educational and 
training materials among recipients and determine to what extent they 
meet relevant service-related DDT objectives and goals.
    The following are examples of the areas of focus that the data 
collection activities under this generic information collection 
mechanism may include:
     Reach, uptake, use, customer experience, and satisfaction 
with the CDC-recognized lifestyle change programs for Type 2 diabetes 
prevention, as well as related outcomes (e.g., participant retention 
and recruitment rates).
     Satisfaction with CDC-recognized lifestyle change programs 
toolkits, such as the Personal Success Tool and Champion toolkits.
     Reach, uptake, use, customer experience, and satisfaction 
with diabetes education, type 2 prevention, and diabetes management 
innovations (such as the Diabetes Self-Management Education and Support 
services promotion initiative) and related short-term effects on 
knowledge, awareness, practices (such as information seeking), and 
outcomes (such as enrollment of people with diabetes or prediabetes).
     Reach, uptake, satisfaction, customer experience, and 
short-term outcomes of CDC's training and technical assistance 
resources (such as a webinar or online toolkit).
     Needs assessments for customer experience with, 
utilization of, and short-term outcomes of technical assistance and 
trainings for diabetes prevention and management.
     Understandability, ease of use, and appropriateness of 
diabetes education messages, toolkits, programs, and marketing 
materials.
     Exploratory assessments of knowledge, attitudes, 
behaviors, beliefs, barriers, and facilitators to uptake and use of 
lifestyle change programs for diabetes type 2 prevention and diabetes 
management services and related innovations, resources, tools, and 
materials.
    Data collection methods proposed include, but are not limited to 
in-depth individual interviews, cognitive interviews, intercept 
interviews, group-based discussions (including focus groups and dyads/
triads), surveys or questionnaires, knowledge assessments, 
observational assessments, and implementation and utilization data 
reporting. Respondents would include key audiences and stakeholders of 
CDC's work, including representatives of state and local DDT-funded 
organizations; national, state, and local DDT partners (not CDC-
funded); providers of type 2 diabetes prevention and diabetes 
management programs and services, including lifestyle coaches, diabetes 
care and educations specialists, healthcare and other providers; heath/
medical and community-based organizations implementing programs and 
services related to type 2 diabetes prevention and diabetes management; 
people with--and at risk for--diabetes or with prediabetes; family, 
friends, and caregivers of people with--and at risk for--diabetes or 
with prediabetes.
    As the methods for data collection and audiences may vary with each 
request submitted under this proposed generic clearance, for each data 
collection request unique instruments (e.g., surveys, interview guides) 
will be developed to address the specific topics that information will 
be collected on.

[[Page 60638]]

Questions to be asked may focus, for example, on collecting data on the 
audiences' needs and on the reach, uptake, use, customer experience and 
satisfaction with DDT's services, products, and programs. Such 
information will enable DDT to identify ways to improve its services, 
products, and programs to better meet its audiences' needs and achieve 
its mission of supporting the prevention of diabetes and reducing 
diabetes-related complications and disparities across the United 
States.
    The estimated annualized hourly burden anticipated for all data 
collection methods would total 2,000 hours and include eight to ten 
data collection activities over the course of a year. There is no cost 
to the respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of
      Type of respondents        Data collection     Number of     responses per  Average burden   Total burden
                                     methods        respondents     respondent     per response        hours
----------------------------------------------------------------------------------------------------------------
Representatives of state and    Interviews;                4,000               1           30/60           2,000
 local DDT-funded                Surveys or
 organizations; National,        Questionnaires;
 State, and Local DDT            Knowledge
 partners; Providers of type 2   Assessments;
 Diabetes Prevention and         Motivation
 Diabetes Management Programs    Assessments,
 and Services; People, family,   Observational
 friends, and caregivers of      Assessments;
 people with--and at risk for--  Implementation
 Diabetes or with Prediabetes.   and Utilization
                                 Data Reporting.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............           2,000
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-16492 Filed 7-25-24; 8:45 am]
BILLING CODE 4163-18-P